Current perspectives on the use of gene therapy for hypertension

Circulation Research

Volumn 87, Issue 12, 2000, Pages 1118-1122

  Gelband, Craig H ^a   Katovich, Michael J ^b   Raizada, Mohan K ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Antisense; Gene therapy; Hypertension; Renal and cardiac pathophysiology; Renin angiotensin system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; ANTISENSE OLIGONUCLEOTIDE; BETA 1 ADRENERGIC RECEPTOR; CALCITONIN GENE RELATED PEPTIDE; NITRIC OXIDE SYNTHASE; PROSTACYCLIN SYNTHASE; PROSTAGLANDIN SYNTHASE; PROTEIN PRECURSOR; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE THERAPY; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY INJURY; NONHUMAN; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT; RISK FACTOR; SHORT SURVEY;

EID: 0034623866     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.87.12.1118     Document Type: Short Survey

References (46)

1. Stroke risk factors and stroke prevention
2. Blood pressure, systolic and diastolic, and cardiovascular risks US population data
3. Risk reduction associated with lowering systolic blood pressure review of clinical trial data
4. Hypertension and the renin-angiotensin system evidence from genetic and transgenic studies
5. The renin-angiotensin system and its receptors
6. The integrated effects of angiotensin II
7. Tissue renin-angiotensin system in myocardial hypertrophy and failure
8. Role of tissue angiotensin II in myocardial remodelling induced by mechanical stress
9. Angiotensin II and long-term arterial pressure regulation the overriding dominance of the kidney
10. Molecular basis of human hypertension role of angiotensinogen
11. Polymorphism of the angiotensin-converting enzyme gene and cardiovascular disease
12. A recurrent theme with a new spin ACE polymorphism and cardiovascular disease
13. A genetic polymorphism in the renin gene of Dahl rats cosegregates with blood pressure
14. Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat
15. Mapping of a quantitative trait locus for blood pressure on rat chromosome 2
16. Recognition and management of pulmonary hypertension
17. Is antisense gene therapy a step in the right direction in the control of hypertension?
18. Viral vectors for gene therapy
19. Experimental kallikrein gene therapy in hypertension, cardiovascular and renal diseases
20. Prolonged reduction of high blood pressure with human nitric oxide synthase gene delivery
21. Adrenomedullin gene delivery reduces blood pressure in spontaneously hypertensive rats
22. Atrial natriuretic peptide gene delivery attenuates hypertension cardiac hypertrophy, and renal injury in salt-sensitive rats
23. Adenovirus-mediated kallikrein gene delivery attenuates hypertension and protects against renal injury in deoxycorticosterone-salt rats
24. 1 receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin
25. Transient decrease in high blood pressure by in vivo transfer of antisense oligodeoxynucleotides against rat angiotensinogen
26. Intravenous injection with antisense oligodeoxynucleotides against angiotensinogen decreases blood pressure in spontaneously hypertensive rats
27. 1R mRNA antisense
28. 1 receptor antisense gene therapy
29. Angiotensin II type 1 receptor antisense gene therapy prevents altered renal vascular calcium homeostasis in hypertension
30. Permanent prevention of hypertension by angiotensin II type I receptor antisense gene therapy
31. Reversal of hypertension by angiotensin II type 1 receptor antisense gene therapy in the adult SHR
32. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
33. ACE antisense prevents altered renal vascular reactivity, but not high blood pressure, in the SHR
34. Transmission of antihypertensive effects of ACE antisense gene therapy from parents to offspring
35. A circulating hypertensive factor in primary hypertension effect of antihypertensive therapy
36. Transmission of hypertension in rats by cross circulation
37. Spontaneous hypertension ion cross-suckled rats
38. Maternal influences on adult blood pressure of SHRs a single pup cross-fostering study
39. Alterations in renal vascular resistance and reactivity in spontaneous hypertension of rats
40. 1-adrenergic receptor mRNA in a single dose produces a profound and prolonged reduction in high blood pressure in spontaneously hypertensive rats
41. 1 antisense oligodeoxynucleotides
42. Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension
43. Gene transfer of endothelial nitric oxide synthase to the lung of the mouse in vivo effect on agonist-induced and flow-mediated vascular responses
44. Gene transter of endothelial nitric oxide synthase to the lung of the mouse in vivo selective rescue of pulmonary hypertension in eNOS-deficient mice
45. In vivo gene transfer of prepro-calcitonin gene-related peptide to the lung attenuates chronic hypoxia-induced pulmonary hypertension in the mouse
46. Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor